Back to Home
Search
Help!

Back to Home
Search
Help!
 Prostatic Specific Antigen
 Screening Test
Prostate Specific Antigen, PSA, is a marker which is specific to the prostate, hence its name. It is considered to be the most useful marker available for diagnosis and management of prostatic carcinoma. Recently, the use of a PSA screening test in conjunction with an annual rectal exam in men over 50 years of age has been recommended for early cancer detection.

The normal range for a PSA test is a value less than 4 mcg/L. Approximately 22% of men with elevated values in the range of 4-9.9 mcg/L may have prostatic carcinoma and when the level exceeds 10 mcg/L the percentage climbs to about 65%.

However this test can be elevated by other benign conditions such as prostatic hyperplasia and inflamation. Approximately one quarter of men with benign prostatic hyperplasia may have elevated levels of PSA. Urinary retention, infection, and procedures such as a biopsy can also cause the PSA value to be elevated. The PSA test results must be evaluated by your physician along with the findings of the physical exam and other studies he/she may perform to make a determination of what the PSA value truely means.

It is also possible for the PSA value to be normal where there is prostatic carcinoma. It is for this reason that the screening test cannot replace, but should be used in conjunction with, an annual rectal examination. As in most cancers, catching the tumor early before it has a chance to spread gives the best chance for fighting the disease.

 Free PSA
The Free PSA is a new blood test currently under study which is believed to be more sensitive than the PSA for detecting prostate cancers. The test improves upon the standard PSA by separating its protein into fractions and men with prostate cancer usually have much lower levels of one of the PSA protein fractions known as "free" PSA. It is hoped that this test will improve the accuracy and reduce cost of diagnosis of prostate cancer. The new test must be reviewed and approved by the FDA before it will become widely available for your physician to use.


Last Modified: 7/27/97,
Copyright © 1994, 1995 University of Texas - Houston Medical School, DPALM MEDIC
All rights reserved.